Clinical Thyroidology for Patients is a collection of summaries of recently published articles from the medical literature that covers the broad spectrum of thyroid disorders.
Starting with the May 2009 issue, Clinical Thyroidology for Patients will be published on a monthly basis and include summaries of research studies that were discussed in the previous month’s issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. Dr. Mazzaferri is the Editor-in-Chief of Clinical
Thyroidology.
August 2010 Volume 3 Issue 8
Now available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for Patients August 2010 Volume 3 Issue8 (PDF file, 621 KB)
TABLE OF CONTENTS – Web Format
THYROID HORMONE AND PREGNANCY Hypothyroxinemia and risk for delays in brain development
Henrichs J et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the Generation R Study. J Clin Endocrinol Metab 2010; jc.2010-0415 [pii];10.1210/jc.2010-0415 [doi].
(PDF File for saving and printing, 104 KB)
THYROID AND PREGNANCY First Trimester TSH levels between 2.5 and 5.0 are associated with increased pregnancy loss
Negro R et al, Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy. J. Clin. Endocrinol. Metab. 95 (9): 2010.
(PDF File for saving and printing, 123 KB)
THYROID CANCER Thyroid Cancer seems to be similar in children and young adults
Machens et al, Papillary Thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. J Pediatr 2010. S0022-3476(10)00326-4 [pii];10.1016/j.jpeds.2010.04.026 [doi].
(PDF File for saving and printing, 110 KB)
GRAVES’ OPTHALMOPATHY Rituximab appears to be effective in the treatment of severe thyroid eye disease
Silkiss RZ, et al. Rituximab for Thyroid Eye Disease. Ophthal Plast Reconstr Surg 2010. DOI: 10.1097/IOP.0b013e3181c4dfde.
(PDF File for saving and printing, 110 KB)
THYROID CANCER The decrease in serum calcitonin concentrations after surgery in patients with medullary thyroid cancer identifies patients with persistent cancer
Faggiano A et al. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. J Clin Endocrinol Metab 2010. 0-0045 [pjc.201ii];10.1210/jc.2010-0045[doi].
(PDF File for saving and printing, 112 KB)
Patient Education
Patient Publications
Connect with Us
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.